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Abstract
Background: With a greater emphasis on cost containment in many health care systems, it has become common
to evaluate each physician’s relative resource use. This study explored the major factors that influence the
economic performance rankings of medical clinics in the Korea National Health Insurance (NHI) program by
assessing the consistency between cost-efficiency indices constructed using different profiling criteria.
Methods: Data on medical care benefit costs for outpatient care at medical clinics nationwide were collected from
the NHI claims database. We calculated eight types of cost-efficiency index with different profiling criteria for each
medical clinic and investigated the agreement between the decile rankings of each index pair using the weighted
kappa statistic.
Results: The exclusion of pharmacy cost lowered agreement between rankings to the lowest level, and differences
in case-mix classification also lowered agreement considerably.
Conclusions: A medical clinic may be identified as either cost-efficient or cost-inefficient, even when using the
same index, depending on the profiling criteria applied. Whether a country has a single insurance or a multiple-
insurer system, it is very important to have standardized profiling criteria for the consolidated management of
health care costs.
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Background
With a greater emphasis on cost containment in many
health care systems, it has become common to evaluate
each physician’s relative resource use [1-6]. The motiva-
tion for this economic profiling is primarily financial in
that physicians identified as being inefficient are consid-
ered to be wasting health plan resources and these phy-
sicians can be encouraged to change their practice
pattern [7].
Previous studies have shown that differences in health
status among patients may influence treatment costs
within defined episode types and that the health care
costs of treated patients may differ significantly among
physicians [5-8]. Efforts to identify physician outliers
who show extreme practice patterns and to encourage
them to change their behaviors have become important
for the management of health care costs [8,9]. The
Korea National Health Insurance (NHI) program detects
such outliers using economic profiles.
The O/E ratio, which compares the observed cost (O)
with the expected cost (E), is the measure typically used
for provider economic profiling [5,10]. In this article, we
refer to this score as cost efficiency; however, health
economists have objected to this usage because they
have long used efficiency to refer to the cost of resources
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patient. In September 2005, a meeting convened by the
Ambulatory Quality Alliance and the National Commit-
tee for Quality Alliance determined that cost efficiency
was an acceptable term for the relative use measure and
that, because it does not control for quality or patient
benefit, it must be distinguished from efficiency,w h i c h
controls for outcomes [11]. Thus, a cost-inefficient phy-
sician here means one who claims more costs than
expected.
Cost − efﬁciency Index =
Observedcos t
Expectedcos t
=O / Er a t i o
H o w e v e r ,e v e nt h es a m ei n d e xm a yr e n d e rd i f f e r e n t
values depending on profiling criteria, including the data
used and risk-adjustment methods. For example, if phar-
macy costs are not included when profiling costs or dif-
ferent case-mix classification systems are applied, this
m a ya f f e c tap r o v i d e r ’s calculated cost efficiency, which
could in turn change his/her performance rating.
Within a single NHI program, multiple monitoring
systems may use the same performance measures but
apply different profiling criteria. This could make it dif-
ficult to achieve cost efficiency in the NHI system.
The present study explored the major factors that
influence the economic performance rankings of medical
clinics in the Korea NHI program by assessing the con-
sistency between cost-efficiency indices constructed
using different profiling criteria.
Methods
1. Study setting
The NHI program of Korea covers the whole popula-
tion as a compulsory social insurance system. The
National Health Insurance Corporation (NHIC) is the
sole insurer and is responsible for operating the pro-
gram; however, the Health Insurance Review Agency
(HIRA) is in charge of reviewing providers’ claims, and
the Ministry of Health and Welfare (MOHW) super-
v i s e st h ep r o g r a ma saw h o l e .I t sm a i ns o u r c e so f
funding are contributions from the insured and gov-
ernment subsidies. Medical care benefit services
include diagnoses, tests, drugs, medical materials, treat-
ments, surgeries, preventative care, rehabilitation, hos-
pitalization, nursing, and transportation. Basically, the
medical care benefit costs are reimbursed through a
fee-for-service system for all services and provider
levels [12].
Patients pay certain portions of treatment costs as co-
payments. The co-payments for outpatient care vary
depending on the total medical charges as well as the
level of health care facility. Inpatient care requires
patients to pay 20% of the total medical charges.
A patient can select any practitioner or any medical
care institution, but to be treated at a secondary hospital
(specialized general hospitals), one must present a refer-
ral slip issued by the doctor who saw the patient first.
Medical care institutions are classified as follows, based
on the number of beds: clinics (fewer than 30 beds), hospi-
tals (30-99 beds), and general hospitals (more than 99
beds); all of these can provide outpatient services [12].
This study was limited to medical clinics, excluding
those that provide eastern medicine or dental services.
Medical clinics were considered to be appropriate for
studying physician-profiling methods because 98%
(25,168) of all clinics (25,789) were sole practices as of
2006 [13].
The reimbursement process starts with medical care
institutions’ submitting claims for their medical services
to HIRA for review. In this fee-for-service reimburse-
ment system, this review is aimed at minimizing the risk
of paying for excessive or unnecessary patient care and
also encouraging more efficient care through profiling
and feedback systems (HIRA, 2008). NHIC makes the
payment to the medical care institution based on the
results of the review [14].
The HIRA has operated two systems to monitor the
practice patterns of medical clinics: the Comprehensive
Management for Appropriate Medical Services System
(CM System) and the Notice System for Autonomous
Corrective Action (Notice System). The CM System is
basically a function of HIRA’s consulting services to med-
ical clinics, and their advice is not legally binding. How-
ever, the Notice System is an operation delegated to the
HIRA by the MOHW, and refusal to take autonomous
corrective action after receiving a notice may lead to an
onsite investigation under the anti-fraud enforcement
program. A medical clinic identified to have made false
claims in an onsite investigation will face an administra-
tive penalty. If the wrongdoing is serious, criminal
charges may also be filed against the institution [14].
Both systems use the O/E ratio to calculate cost effi-
ciency, but profiling criteria suggested for the two sys-
tems are different. The Notice System was developed in
1986, and no established patient classification system
existed at that time. Instead, the system classified
patients with the three-digit code of the Korean Classifi-
cation of Disease(KCD) developed on the basis of the
International Classification of Diseases-Tenth Edition
(ICD-10), and subdivided into 2 groups depending on
whether the patient had a surgical operation or not.
Medical clinics claimed pharmacy costs as well as pro-
fessional costs until the separation of prescribing and
dispensing medicine was implemented in 2000; since
then, medical clinics have claimed professional costs
only, and the cost-efficiency index of the Notice System
has been bases solely on professional costs [15].
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used for case-mix classification, and each clinic’sc o s t -
efficiency index is calculated based on medical care ben-
efit costs, which include professional costs and drug
costs. This is aimed at controlling pharmaceutical costs
by placing responsibility for prescription drug costs on
medical clinics and limiting their prescriptions.
The KOPG system was developed by the HIRA in 2003,
with reference to the American Ambulatory Patient
Groups, version 2.0, taking into account the clinical char-
acteristics of ambulatory patients and the similarity of
their resource use [16,17]. In this system, all claims are
classified according to significant outpatient procedures or
therapies. Those claims with significant outpatient proce-
dures are divided into 172 groups according to patient
age. The other claims are divided into 262 groups accord-
ing to patient age using subcategories of the KCD or are
divided into five error-KOPG groups and 43 ancillary-
only-KOPG groups by ancillary tests or procedures [17].
Although these two systems were developed at differ-
ent times, they have a similar process and objective: to
profile medical care institutions on their relative costs
and to inform those medical care institutions of the out-
comes, thereby encouraging them to change their prac-
tice patterns. However, because the NHI program has
been operating the two systems simultaneously since
2003, some medical clinics have received contradictory
information from the two systems and have complained
about the reliability of that information. Accordingly,
increasing attention has been paid to the main factors
that reduce the level of agreement between the indices of
the two systems.
2. Study data and measures
Study data on medical care benefit costs for outpatient
care at nationwide medical clinics were collected from
the claims database which HIRA reviewed in April 2007.
We excluded 13 specialty clinics, such as pneumonolgy,
clinical pathology, and anatomic pathology, because
each specialty had fewer than 10 clinics across Korea.
Study subjects finally recruited were 23,112 medical
clinics and 22,088,649 patients who visited these clinics.
The specialty classification of a medical clinic with more
than one practicing physician was based on the chief
physician’s specialty. The number of clinics and their
patients by specialty are presented in Table 1. The pro-
portion of pharmacy costs against total costs was, on
average, 29.76%. The lowest proportion of pharmacy
costs was shown in diagnostic radiology (10.61%), and
the highest portion in internal medicine (38.23%). The
correlation coefficient between medical care benefit
Table 1 Number of clinics and their patients, proportion of pharmacy costs, and correlation between total costs
including and excluding pharmacy costs by specialty
Specialty No. of clinics No. of
patients
% of total cost
represented by
pharmacy cost
(mean ± sd)
Correlation between costs including
and excluding pharmacy costs
1)
General clinics 4,695 3,807,917 32.04 ± 23.84 0.99
Internal medicine 3,611 4,852,887 38.23 ± 25.23 0.87
Pediatrics 2,128 2,333,778 26.18 ± 19.80 0.99
Otorhinolaryngology 1,737 2,561,254 24.10 ± 15.40 0.99
Orthopedic surgery 1,725 1,585,045 20.23 ± 21.56 0.99
Obstetrics & gynecology 1,604 873,524 21.09 ± 20.82 0.98
Ophthalmology 1,207 1,515,235 23.38 ± 17.31 0.97
General surgery 1,193 794,618 27.65 ± 23.32 0.97
Family medicine 1,055 1,009,541 34.11 ± 23.20 0.95
Urology 888 581,503 30.82 ± 23.46 0.90
Dermatology 803 779,600 29.02 ± 21.96 0.93
Psychiatry 708 308,835 19.00 ± 27.05 0.99
Anesthesiology 588 296,653 28.90 ± 25.95 0.99
Neurosurgery 362 298,801 27.49 ± 25.29 0.99
Rehabilitation medicine 276 158,182 27.17 ± 26.74 0.99
Diagnostic radiology 244 156,622 10.61 ± 21.37 0.96
Neurology 132 104,304 41.56 ± 28.60 0.92
Thoracic surgery 82 64,099 31.97 ± 23.83 0.97
Plastic surgery 74 6,251 13.22 ± 20.15 0.98
Total 23,112 22,088,649 29.76 ± 23.80 0.95
1) Pearson’s correlation coefficient
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pharmacy costs was lowest in internal medicine (0.87).
However, as the mean coefficient (0.95) shows, it was
high overall.
The cost-efficiency index is termed the costliness
index (CI) in the CM System, whereas it is called the Y
Index in the Notice System. In this study, however, the
general term cost-efficiency index was used because this
study focused on evaluating the agreement between
cost-efficiency indices with different profiling criteria.
We created eight types of cost-efficiency index by cross-
substituting different profiling criteria suggested in the
Notice System and the CM System (Table 2).
The formula for calculating the cost-efficiency index is
as follows:
the h clinic’s cost-efficiency index,
CIh =
Observed cost
Expected cost
=
n 
g=1
Chg × Nhg
n 
g=1
Cg × Nhg
h: clinic,
g: by case-mix classification (KOPG or KCD &
surgery),
Nhg: the number of cases (patients) by case-mix clas-
sification in the h clinic,
Cg: average costs by case-mix classification in clinics
with the same specialty as the h clinic,
Chg: average costs by case-mix classification in the h
clinic
The CM System and Notice System have different
case-mix classification, data range, and cost range in
profiling criteria. The Notice System’s case-mix classifi-
cation categorizes a patient with a three-digit code
based on the primary diagnosis (KCD) and his or her
surgery experience, whereas the CM System follows the
system developed by the KOPG. In terms of data range,
the Notice System calculates each clinic’s efficiency
index based solely on the patients who visited with one
of the 300 frequent disease groups of the same specialty
clinics; this accounts for more than 90% of all cases.
Table 2 Cost-efficiency indices and their profiling criteria
Cost-efficiency (CI) indices Case-mix classification Data range Cost range
KCD & surgery
experience
KOPG 300 most
frequent
disease cases
All
cases
Excluding pharmacy
costs
Including pharmacy
costs
CI_1 KOPG,
all cases, including
pharmacy costs
YY Y
CI_2 KOPG,
all cases, excluding
pharmacy costs
YY Y
CI_3 KOPG, 300 most
frequent disease
cases, including
pharmacy costs
YY Y
CI_4 KOPG, 300 most
frequent disease
cases, excluding
pharmacy costs
YY Y
CI_5 KCD & surgery, all cases,
including
pharmacy costs
YY Y
CI_6 KCD & surgery, all cases,
excluding
pharmacy costs
YY Y
CI_7 KCD & surgery, 300 most
frequent
disease cases, including
pharmacy
costs
YY Y
CI_8 KCD & surgery, 300 most
frequent
disease cases, excluding
pharmacy
costs
YY Y
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to cost range, pharmacy costs are excluded from total
costs in the Notice System but included in the CM Sys-
tem. In Table 2 and Figure 1, CI_1 is the same as the
CI in the CM System, and CI_8 is the same as the Y
Index in the Notice System.
3. Statistical analyses
We calculated eight types of cost-efficiency index for
ambulatory care costs at a medical clinic and investi-
gated the agreement between index rankings to explore
the main factors that influence their agreement. The
agreement between indices at high and low outlier
thresholds of 10% was explored, and then the agreement
between decile rankings of the two indices was assessed
using the weighted kappa statistic proposed by Landis
and Koch [18]. If the ranges of two indices agree com-
pletely, the kappa statistic is near or equal to 1; if they
lack agreement, the kappa statistic is near or equal to 0.
When a kappa statistic is greater than 0.8, the agree-
ment between indices can be interpreted as a very good
or almost perfect agreement. Also, agreement in the
range of 0.61-0.80 is interpreted as good or substantial
agreement, whereas 0.41-60 is moderate agreement,
0.21-0.40 is fair agreement, and less than 0.20 is poor
agreement. Generally, if kappa is less than 0.4, the
agreement is interpreted as not good [18,19]. Analyses
were conducting using SAS (ver. 9.1).
Results
1. High outlier agreement and low outlier agreement
When we investigated the agreement at the high outlier
threshold of 10% between CI_1 and each cost-efficiency
index alternative, the highest rate of agreement (99.9%)
was observed in the pair of CI_1 and CI_3, which
differed in data ranges. In the pair of CI_1 and CI_5,
which differed in case-mix classifications, the rate of
agreement fell to 68.6%. It was reduced further to 57.5%
in the pair of CI_1 and CI_2, which differed in cost
ranges. The lowest level of high outlier agreement was
shown in the pair of CI_1 and CI_6 and that of CI_1
and CI_8, where agreement was 44.7% and 44.8%,
respectively. CI_1 and CI_6 differed from each other in
case-mix classification, data range, and cost range,
whereas CI_1 and CI_8 differed in case-mix classifica-
tion and cost range. However, in all pairs, little variation
in agreement was due to a difference in data range. The
low outlier agreement also showed the same trend as
the high outlier agreement in each pair of cost-efficiency
index alternatives (Table 3).
2. Agreement between decile rankings
When CI_1, the baseline cost-efficiency index, was com-
pared with each cost-efficiency index alternative to
assess the agreement between the decile rankings using
the weighted kappa statistic, the highest level of agree-
ment was observed in CI_3 (k = 0.99), which differed in
data range compared with CI_1 (Figure 1). The lowest
l e v e lo fa g r e e m e n tw a ss h o w ni nC I _ 6a n dC I _ 8( k=
0.43), which differed from CI_1 in case-mix classifica-
t i o na n dc o s tr a n g e .C I _ 6a n dC I _ 8d i f f e r e di nd a t a
range. The pair of CI_1 and CI_8 demonstrates how the
profiling criteria of the CM System and the Notice Sys-
tem differ (k = 0.43). For the pair of CI_1 and CI_2 in
terms of total costs, including and excluding pharmacy
costs, the weighted kappa statistic was 0.55, whereas in
the pair of CI_1 and CI_5, with different case-mix classi-
fications, it was 0.71. Thus, the inclusion or exclusion of
pharmacy costs was shown to have a greater effect on
agreement than a difference in case-mix classification
had.
The agreement of decile rankings between CI_1 and
each cost-efficiency index alternative was further ana-
lyzed according to physician specialty (Table 4). In the
pair of CI_1 and CI_2, with regard to total costs includ-
ing and excluding pharmacy costs, internal medicine
showed the lowest agreement of decile rankings (k =
0.37). However, surgical specialties, such as orthopedic
Figure 1 Agreement in decile rankings between the baseline
cost-efficiency index (CI_1) and each cost-efficiency index
alternative assessed using the weighted kappa statistic.
Table 3 Agreement at high and low outlier thresholds of
10%: number of clinics by alternative cost-efficiency
indices and their percentage relative to the baseline
cost-efficiency index
CI_1 CI_2 CI_3 CI_4 CI_5 CI_6 CI_7 CI_8
high outlier
10%
2,311
(100.0)
1,328
(57.5)
2,308
(99.9)
1,328
(57.5)
1,585
(68.6)
1,033
(44.7)
1,585
(68.6)
1,035
(44.8)
low outlier
10%
2,310
(100.0)
1,317
(57.0)
2,308
(99.9)
1,316
(57.0)
1,685
(72.9)
1,033
(44.7)
1,681
(72.7)
1,030
(44.6)
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medicine, and diagnostic radiology, had a statistically
high level of agreement. Variations in agreement due to
a difference in case-mix classification were smaller than
were those due to pharmacy costs. However, in the case
of case-mix classifications, medical specialties showed
relatively high agreement.
Discussion
In medical clinics under the Korea NHI program, the
cost-efficiency index calculated using all cases and that
calculated using only those cases that present with one
of the 300 most frequent disease groups were barely dif-
ferent. The greatest difference between cost-efficiency
indices resulted from differential policies with regard to
pharmacy costs. When the cost-efficiency index for total
costs including pharmacy costs was compared with the
index for total costs excluding pharmacy cost, the agree-
ment between the two indices was only 55%. The agree-
ment between indices was also reduced, to 71%, when a
difference in case-mix classification was involved. How-
ever, case-mix classification was less influential than was
cost range. Among all pairs of cost-efficiency indices,
the lowest level of agreement (43%) was observed
between CI_1 and CI_8. This pair differed in three cri-
teria: data range, cost range, and case-mix classification.
These results suggest that the application of different
profiling criteria to similar indices may result in contra-
dictory outcomes that may be confusing to a medical
institution and may impair the reliability of provider-
profiling systems. Thus, the standardization of profiling
criteria among provider feedback systems is important
for achieving more efficient spending at the macro level
of the insurance program.
Because we cannot know in real terms whether a cost-
efficiency index calculated for a health care provider
using claims data informs us of correct rankings, we
cannot evaluate the validity of the index directly [5].
The reliability of the cost-efficiency index is thus impor-
tant in terms of its utilization [4]. From the insurance
administrator’s point of view, the cost-efficiency index
for a health care provider is used to identify a physician
who has tended to provide higher- or lower-cost ser-
vices than expected to patients [1]. In the United States,
provider-profiling systems were introduced or adopted
mostly by managed care insurers who needed to manage
insurance finances [2,4,20]. Recently Medicare, a social
insurance program administered by the United States
government, has also implemented a resource-utilization
report plan through which information on cost effi-
ciency is provided to an individual provider as a way of
slowing the trend toward increasing health care costs
[21].
This result is not consistent with the findings of Tho-
mas (2006), who evaluated the agreement among decile
rankings of cost-efficiency indices for total costs includ-
ing pharmacy costs and excluding pharmacy costs using
claims data from physicians who were enrolled in a uni-
versity-owned mixed-model health maintenance organi-
zation in southeastern Michigan, USA, using the
weighted kappa statistic [11]. The inclusion or exclusion
of pharmacy costs did not greatly affect the rankings.
However, Thomas suggested that attention needs to be
paid to the effect of excluding pharmacy costs in the
case of clinical specialties for which the proportion of
pharmacy costs to total costs is relatively high and those
in which the correlation between costs including phar-
macy costs and those excluding pharmacy costs is rela-
tively low. Our findings confirm the need for such
attention.
In the present study, differences among profiling cri-
teria affected cost-efficiency profiling to different
degrees depending on specialty and the ratio of phar-
macy costs to total costs (Tables 1 and 4).
Two specialties discussed in the study by Thomas
(2006) with regard to the effect of excluding pharmacy
costs were cardiology and neurology [11]. The percen-
tages of total costs represented by pharmacy costs in
these specialties were 28% and 36%, respectively, and
the correlation between costs with and without phar-
macy costs were 0.975 and 0.903, respectively. In our
Table 4 Agreement in decile rankings between the
baseline cost-efficiency index and each cost-efficiency
index alternative by specialty, assessed using the
weighted kappa statistic
Specialty CI_1 CI_2 CI_3 CI_4 CI_5 CI_6 CI_7 CI_8
General clinics 0.49 0.99 0.49 0.64 0.33 0.63 0.33
Internal medicine 0.37 1.00 0.37 0.80 0.33 0.80 0.33
Pediatrics 0.65 1.00 0.65 0.90 0.62 0.89 0.62
Otorhinolaryngology 0.61 1.00 0.61 0.55 0.36 0.55 0.36
Orthopedic surgery 0.72 1.00 0.72 0.70 0.56 0.70 0.56
Obstetrics &
gynecology
0.64 1.00 0.64 0.80 0.58 0.80 0.57
Ophthalmology 0.56 1.00 0.56 0.80 0.52 0.80 0.52
General surgery 0.56 1.00 0.56 0.65 0.40 0.65 0.39
Urology 0.40 1.00 0.40 0.76 0.37 0.76 0.37
Dermatology 0.41 1.00 0.41 0.77 0.40 0.77 0.40
Family medicine 0.45 1.00 0.45 0.72 0.34 0.71 0.34
Psychiatry 0.67 1.00 0.67 0.62 0.51 0.62 0.51
Anesthesiology 0.75 1.00 0.75 0.65 0.52 0.65 0.52
Neurosurgery 0.70 1.00 0.70 0.64 0.47 0.64 0.47
Rehabilitation
medicine
0.83 1.00 0.83 0.66 0.56 0.66 0.56
Diagnostic radiology 0.79 1.00 0.79 0.82 0.71 0.81 0.68
Neurology 0.43 1.00 0.43 0.62 0.31 0.62 0.32
Plastic surgery 0.83 1.00 0.83 0.68 0.63 0.68 0.63
Thoracic surgery 0.64 1.00 0.64 0.54 0.37 0.54 0.38
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was, on average, 29.8%, a relatively high level, whereas
many specialties had low correlations between costs
with and without pharmacy costs. Accordingly, the
exclusion of pharmacy costs is understood to have
resulted in the underestimation of costs expended by
healthcare providers, which greatly lowered the overall
agreement between indices (Tables 1 and 4). Addition-
ally, the level of agreement was at its lowest in internal
medicine, which was characterized by the highest pro-
portion of pharmacy costs and the lowest correlation
between total costs with and without pharmacy costs
among specialties. This result suggests that if a provider
specialty shows a high proportion of pharmacy costs, we
need to take into account whether pharmacy costs were
included in total costs when profiling the provider.
The agreement between two index alternatives with a
difference in case-mix classification was 71%, indicating
that the agreement between indices is also affected by
case-mix classification. However, this is still higher than
the agreement between two indices for which the phar-
macy cost is a factor, and 71% itself is statistically good
agreement. Such results indicate that although the accu-
racy of case-mix adjustment methods also may affect
agreement between indices, case-mix adjustment is still
very important for the reliability and accuracy of provi-
der profiling [5,22,23]. In the same specialty group,
some physicians may treat patients with clinically diffi-
cult conditions and may therefore incur higher costs
than expected. Thus, case-mix adjustment is also impor-
tant for equitable physician profiling [7,10,24].
Our study has several advantages over previous ones.
First, despite the usefulness of cost-efficiency indices, their
reliability has been questioned by some providers. How-
ever, few studies have addressed the reliability and accu-
racy of cost-efficiency indices [4,5,21,23]. We analyzed the
agreement between indices with the same formula but dif-
ferent profiling criteria compared to those used in provi-
der-profiling systems under the Korea NHI program.
Second, we attempted to identify important factors
that must be taken into account to improve the accu-
racy and reliability of cost-efficiency indices. Due to a
much easier access to a computerized database of
claims, provider profiling has increasingly been intro-
duced at various areas and levels of medical institutions
under the Korea NHI program. In line with this trend,
the likelihood that cost-efficiency indices with the same
objective would have different values due to differences
in profiling criteria is also increasing. By revealing such
factors for consideration, we hope our study provides a
useful cautionary message to governments or insurers
who are planning the extensive application of physician
profiling.
Third, we calculated and analyzed cost-efficiency
indices for 23,112 medical clinics that claimed costs
from the Korean NHI program in April 2007. These
clinics correspond to 90% of the 25,780 medical
clinics registered at the Health Insurance Review and
Assessment Service of Korea (HIRA) as of the end of
2006 [12]. Thus, our study subjects represented
almost all medical clinics operating under the Kor-
ean NHI program at that time. As we analyzed
almost all medical clinics, our results can be
regarded by other countries or healthcare systems as
valuable evidence with respect to enhancing agree-
ment between indices
However, the time lag between when services are pro-
vided and when they are billed could be a limitation of
our study. HIRA builds a database when claims are sub-
mitted, and one of the reasons for doing so is to moni-
tor cost efficiency for a medical institution and thereby
to provide relevant feedback as soon as possible. If
HIRA chooses to monitor cost efficiency using claims
data constructed by the incurred time, this will lead to a
delay until all claims of that time have been filed. In rea-
lity, as the National Health Insurance Act of Korea sets
forth, the insurer shall pay for medical care benefit costs
without delay upon a medical institution’s filing a claim,
and most medical institutions submit their claims in a
batch every month. In the April 2007 database that we
used, 95% of cases occurred within 3 months before
the claim, thus minimizing any potential influence of
the time lag between services rendered and claim
acceptance.
In addition, we took the average costs of medical
clinics with the same specialty as each clinic’se x p e c t e d
cost. This is a common method when profiling a provi-
der’s performance, although the additional costs of car-
ing for more patients or sicker patients cannot be fully
adjusted across medical clinics [25]. Multivariate regres-
sion models can be used to estimate the expected costs
of each provider, using R-square values for a valid com-
parison of different systems of physician profiling. It
should be used for the further study.
If profiling outcomes for a health care provider differ
by insurer, the provider is unlikely to trust the profiling
bodies, and this could make the consolidated manage-
ment of costs more difficult. An effort to standardize
profiling criteria for indices among similar systems in a
universal health insurance system, as in Korea, and
among related organizations in a multi-insurers system
is thus required. To enhance the accuracy and reliability
of physician profiling indices, above all, the standardiza-
tion of methods of determining cost range and of case-
mix adjustment, as presented in this study, must be
initiated.
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Page 7 of 8Conclusion
It is becoming increasingly common to profile health
care providers according to their relative resource use,
and relevant cost-efficiency indices have been developed
accordingly. The objective of a cost-efficiency profiling
system is to encourage cost-inefficient healthcare provi-
ders to change their practice patterns by providing feed-
back on their cost efficiency. However, although the
same cost-efficiency index is applied, a health care pro-
vider may be profiled as either efficient or inefficient,
depending on the profiling criteria. Whether a country
has universal health insurance, like Korea, or a multiple-
insurers system, it is very important to standardize pro-
filing criteria for the reliability and accuracy of cost-effi-
ciency indices and, ultimately, for the consolidated
management of healthcare costs. When standardizing
profiling criteria, two factors especially must be taken
into account: the inclusion or exclusion of pharmacy
costs in total costs and the method of case-mix
classification.
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